Advertisement
Advertisement

PRCT

PRCT logo

PROCEPT BioRobotics Corporation Common Stock

26.12
USD
Sponsored
-0.26
-0.99%
May 15, 15:59 UTC -4
Closed
exchange

After-Market

26.11

-0.02
-0.06%

PRCT Earnings Reports

Positive Surprise Ratio

PRCT beat 11 of 19 last estimates.

58%

Next Report

Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$94.92M
/
-$0.45
Implied change from Q1 26 (Revenue/ EPS)
+14.18%
/
-19.64%
Implied change from Q2 25 (Revenue/ EPS)
+19.88%
/
+28.57%

PROCEPT BioRobotics Corporation Common Stock earnings per share and revenue

On Apr 29, 2026, PRCT reported earnings of -0.56 USD per share (EPS) for Q1 26, beating the estimate of -0.56 USD, resulting in a 1.34% surprise. Revenue reached 83.13 million, compared to an expected 82.12 million, with a 1.24% difference. The market reacted with a +10.73% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 14 analysts forecast an EPS of -0.45 USD, with revenue projected to reach 94.92 million USD, implying an decrease of -19.64% EPS, and increase of 14.18% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
ClearPoint Neuro, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.27
Actual
-$0.32
Surprise
-14.78%
logo
Microbot Medical, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.05
Surprise
+36.06%
logo
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.25
Actual
-$0.31
Surprise
-23.21%
logo
Solana Company Class A Common Stock (DE)
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.48
Actual
-$1.03
Surprise
-110.38%
logo
Xtant Medical Holdings, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.01
Actual
-$0.02
Surprise
-17.65%
logo
DarioHealth Corp. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$1.50
Actual
-$1.25
Surprise
+17.20%
logo
SiNtx Technologies, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.67
Actual
-$0.70
Surprise
-3.98%
logo
PAVmed Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.71
Actual
-$4.42
Surprise
-519.05%
logo
Tenon Medical, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.28
Surprise
+6.78%
logo
NexGel, Inc Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.11
Surprise
-54.06%
FAQ
For Q1 2026, PROCEPT BioRobotics Corporation Common Stock reported EPS of -$0.56, beating estimates by 1.34%, and revenue of $83.13M, 1.24% above expectations.
The stock price moved up 10.73%, changed from $21.71 before the earnings release to $24.04 the day after.
The next earning report is scheduled for Aug 04, 2026.
Based on 14 analysts, PROCEPT BioRobotics Corporation Common Stock is expected to report EPS of -$0.45 and revenue of $94.92M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement